Webpackaging logo

Why do professionals attend CPhI North America?

North America, USA, US - The Northeast, Health, Pharmaceuticals, Shows, Associations, Media, Packaging Trade Shows, Events, CPHI

CPhI North America unites the entire pharmaceutical ecosystem. Professionals on the cutting-edge of our ever-evolving industry, all determined to grow their professional network, secure vital business connections, find new solutions, and even seal some deals.

Here are four of the key reasons thousands of your contemporaries mark their calendars for the year’s most important (and complete) pharma event…

Revitalize key partnerships and forge new ones

Nothing compares to face-to-face networking, and with 7,400+ of North America’s most influential pharma players together, there’s big business to conduct.

Source innovative solutions from 630+ vendors

The massive (93k square feet!), yet easy-to-navigate show floor has all your solutions strategically-placed in seven unique zones, including new-for-2018 biopharmeceuticals and machinery zones!

Exclusive, free access to powerful keynote presentations

Step away from the bustling Expo Hall and recharge as you enjoy motivational keynote speakers with breakthrough ideas on everything from manufacturing to outsourcing, R&D, drug delivery, and more.

Learn from today’s industry trailblazers.

Two free-to-attend show floor theaters will feature talks and presentations about
the newest and most innovative products and business solutions.

It’s no secret that North America is home to the most innovative and progressive pharmaceutical supply chain in the world. See it all and meet the best of the best at CPhI North America taking place from April 24-26 at the Pennsylvania Convention Center, Philadelphia, PA, USA!

See also

New finished product manufacturing hub in the Middle East

A new report by CPhI forecasts sizable changes ahead for the pharma markets in the Middle East and Africa over the next few years. It highlights recent regulatory changes, coupled with increased geopolitical stability and rising generics consumption as key drivers in transforming the prospects of pharma manufacturers in the region. The CPhI Middle East and Africa report – released ahead of the inaugural edition of CPhI MEA, has identified significant opportunities for a region that is often overlooked by much of international pharma.

  • Company News
  • English
  • Modified 19 Dec 2017
  • Hits 1097